NIPT stands for Non-Invasive Prenatal Testing. It’s a screening test that analyzes cell-free fetal DNA circulating in the mother’s bloodstream to assess the risk of certain chromosomal abnormalities in the fetus. NIPT is often used to screen for common chromosomal disorders such as Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and Patau syndrome (trisomy 13), as well as certain sex chromosome abnormalities, such as Turner syndrome (monosomy X) and Klinefelter syndrome (XXY).
NIPT offers an effective and non-invasive option for prenatal screening of common chromosomal abnormalities, providing valuable information to pregnant individuals and healthcare providers to guide pregnancy management and decision-making. However, it’s important to recognize that NIPT is a screening test and does not provide a definitive diagnosis of fetal chromosomal abnormalities. Positive results should be followed up with confirmatory diagnostic testing for conclusive diagnosis and counseling.
Our team of highly experienced doctors and medical professionals is here to provide you with top-notch care throughout treatment
Our team of highly experienced doctors and medical professionals is here to provide you with top-notch care throughout treatment
Duis aute irure dolor in reprehenderit in voluptate velit
esse cillum dolore eu fugiat nulla pariatur.